Paycor HCMの空売り状況は、投資家がPaycor HCMの株価下落に賭けている度合いを知ることができます。空売りデータは2週間ごとに更新されます。

Paycor HCM (NASDAQ:PYCR) 株価情報, 空売り情報

Paycor HCM

Paycor HCM provides payroll and human capital management solutions to small and midsize clients in the United States via a software-as-a-service model. Alongside core payroll functionality, the firm's platform offers a suite of HCM solutions including talent management and time and attendance software, third-party integration capabilities, and industry-specific configurations. The firm targets customers with 10-1,000 employees and had over 30,500 customers as of June 2024.

Paycor HCM Inc

Curbline Properties (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CURB#NYSE">CURB</a>) underwent analysis by 4 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $27.0, along with a high estimate of $31.00 and a low estimate of $24.00. Witnessing a positive shift, the current average has risen by 3.85% from the previous average price target of $26.00.
<img src="https://www.benzinga.com/files/images/story/2025/1739390462_0.png" alt="price target chart" />
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
The standing of Curbline Properties among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Alex Goldfarb</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Overweight</td>
<td>$31.00</td>
<td>$28.00</td>
</tr>
<tr>
<td>Floris Van Dijkum</td>
<td>Compass Point</td>
<td>Raises</td>
<td>Neutral</td>
<td>$26.00</td>
<td>$24.00</td>
</tr>
<tr>
<td>Ronald Kamdem</td>
<td>Morgan Stanley</td>
<td>Announces</td>
<td>Equal-Weight</td>
<td>$27.00</td>
<td>-</td>
</tr>
<tr>
<td>Floris Van Dijkum</td>
<td>Compass Point</td>
<td>Announces</td>
<td>Neutral</td>
<td>$24.00</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Curbline Properties. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Curbline Properties compared to the broader market.</li>
<li>Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of Curbline Properties's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Curbline Properties's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/CURB/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Curbline Properties analyst ratings.</a>
<h2>About Curbline Properties</h2>
Curbline Properties Corp is a publicly-traded REIT operating Convenience retail properties, offering enhanced access and visibility relative to other retail property types. The properties generally consist of a ubiquitous row of shop units along with dedicated parking leased to a diversified mixture of national and local service and restaurant tenants that cater to daily convenience trips from the growing suburban population.
<h3>Key Indicators: Curbline Properties's Financial Health</h3>
Market Capitalization Analysis: Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.
Revenue Growth: Over the 3 months period, Curbline Properties showcased positive performance, achieving a revenue growth rate of 22.92% as of 30 September, 2024. This reflects a substantial increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Real Estate sector.
Net Margin: Curbline Properties's net margin is below industry averages, indicating potential challenges in maintaining strong profitability. With a net margin of -52.1%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Curbline Properties's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of -1.14%, the company may face hurdles in achieving optimal financial returns.
Return on Assets (ROA): Curbline Properties's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of -1.1%, the company may face hurdles in achieving optimal financial performance.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.03.
<h2>The Basics of Analyst Ratings</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Ratings

CURB

Analyst Expectations For Curbline Properties's Future

In the latest quarter, 4 analysts provided ratings for Staar Surgical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STAA#NASDAQ">STAA</a>), showcasing a mix of bullish and bearish perspectives.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $23.0, a high estimate of $28.00, and a low estimate of $16.00. Observing a downward trend, the current average is 32.85% lower than the prior average price target of $34.25. 
<img src="https://www.benzinga.com/files/images/story/2025/1739390453_0.png" alt="price target chart" />
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive Staar Surgical. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Thomas Stephan</td>
<td>Stifel</td>
<td>Lowers</td>
<td>Buy</td>
<td>$20.00</td>
<td>$38.00</td>
</tr>
<tr>
<td>Mason Carrico</td>
<td>Stephens &amp; Co.</td>
<td>Maintains</td>
<td>Equal-Weight</td>
<td>$28.00</td>
<td>$28.00</td>
</tr>
<tr>
<td>Matt O'Brien</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$16.00</td>
<td>$40.00</td>
</tr>
<tr>
<td>Jon Young</td>
<td>Canaccord Genuity</td>
<td>Lowers</td>
<td>Hold</td>
<td>$28.00</td>
<td>$31.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Staar Surgical. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Staar Surgical compared to the broader market.</li>
<li>Price Targets: Gaining insights, analysts provide estimates for the future value of Staar Surgical's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Staar Surgical's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/STAA/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Staar Surgical analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.
<h2>All You Need to Know About Staar Surgical</h2>
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of sales are generated from the ophthalmic surgical product segment.
<h3>A Deep Dive into Staar Surgical's Financials</h3>
Market Capitalization Analysis: Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.
Revenue Growth: Staar Surgical's remarkable performance in 3 months is evident. As of 30 September, 2024, the company achieved an impressive revenue growth rate of 10.31%. This signifies a substantial increase in the company's top-line earnings. When compared to others in the Health Care sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: Staar Surgical's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 11.27%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): Staar Surgical's ROE excels beyond industry benchmarks, reaching 2.38%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): Staar Surgical's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of 1.9%, the company showcases efficient use of assets and strong financial health.
Debt Management: With a below-average debt-to-equity ratio of 0.09, Staar Surgical adopts a prudent financial strategy, indicating a balanced approach to debt management.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

STAA

Analyst Expectations For Staar Surgical's Future

Ratings for OneStream (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OS#NASDAQ">OS</a>) were provided by 8 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">3</td>
<td align="right">3</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $34.88, a high estimate of $40.00, and a low estimate of $26.00. A decline of 2.21% from the prior average price target is evident in the current average. 
<img src="https://www.benzinga.com/files/images/story/2025/1739390446_0.png" alt="price target chart" />
<h2>Diving into Analyst Ratings: An In-Depth Exploration</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive OneStream. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Daniel Jester</td>
<td>BMO Capital</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$34.00</td>
<td>$38.00</td>
</tr>
<tr>
<td>John Difucci</td>
<td>Guggenheim</td>
<td>Maintains</td>
<td>Buy</td>
<td>$35.00</td>
<td>$35.00</td>
</tr>
<tr>
<td>Scott Berg</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$38.00</td>
<td>$38.00</td>
</tr>
<tr>
<td>Mark Murphy</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$26.00</td>
<td>$30.00</td>
</tr>
<tr>
<td>Steven Enders</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$32.00</td>
<td>$36.00</td>
</tr>
<tr>
<td>Chris Quintero</td>
<td>Morgan Stanley</td>
<td>Maintains</td>
<td>Overweight</td>
<td>$37.00</td>
<td>$37.00</td>
</tr>
<tr>
<td>Daniel Ives</td>
<td>Wedbush</td>
<td>Announces</td>
<td>Outperform</td>
<td>$40.00</td>
<td>-</td>
</tr>
<tr>
<td>Adam Hotchkiss</td>
<td>Goldman Sachs</td>
<td>Announces</td>
<td>Buy</td>
<td>$37.00</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to OneStream. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of OneStream compared to the broader market.</li>
<li>Price Targets: Analysts provide insights into price targets, offering estimates for the future value of OneStream's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of OneStream's market position. Stay informed and make well-informed decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/OS/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on OneStream analyst ratings.</a>
<h2>Discovering OneStream: A Closer Look</h2>
OneStream Inc is an AI-enabled and extensible software platform that unifies core financial functions and broader operational data and processes within a single platform. The Digital Finance Cloud of the company provides a comprehensive, dynamic, and predictive view of the entire enterprise, providing corporate leaders the control, visibility, and agility required to proactively adjust business and day-to-day execution.
<h3>Key Indicators: OneStream's Financial Health</h3>
Market Capitalization: Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.
Revenue Growth: OneStream displayed positive results in 3 months. As of 30 September, 2024, the company achieved a solid revenue growth rate of approximately 20.69%. This indicates a notable increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Information Technology sector.
Net Margin: The company's net margin is below industry benchmarks, signaling potential difficulties in achieving strong profitability. With a net margin of -133.14%, the company may need to address challenges in effective cost control.
Return on Equity (ROE): The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of -80.43%, the company may need to address challenges in generating satisfactory returns for shareholders.
Return on Assets (ROA): OneStream's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of -30.44%, the company may face hurdles in achieving optimal financial returns.
Debt Management: OneStream's debt-to-equity ratio is below the industry average. With a ratio of 0.06, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Beyond The Numbers: 8 Analysts Discuss OneStream Stock

21 analysts have shared their evaluations of Exelixis (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXEL#NASDAQ">EXEL</a>) during the recent three months, expressing a mix of bullish and bearish perspectives.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">7</td>
<td align="right">7</td>
<td align="right">7</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">3</td>
<td align="right">6</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
In the assessment of 12-month price targets, analysts unveil insights for Exelixis, presenting an average target of $38.71, a high estimate of $45.00, and a low estimate of $29.00. Surpassing the previous average price target of $35.67, the current average has increased by 8.52%.
<img src="https://www.benzinga.com/files/images/story/2025/1739390435_0.png" alt="price target chart" />
<h2>Understanding Analyst Ratings: A Comprehensive Breakdown</h2>
The standing of Exelixis among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>David Lebowitz</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Buy</td>
<td>$45.00</td>
<td>$38.00</td>
</tr>
<tr>
<td>Michael Schmidt</td>
<td>Guggenheim</td>
<td>Maintains</td>
<td>Buy</td>
<td>$42.00</td>
<td>$42.00</td>
</tr>
<tr>
<td>Sudan Loganathan</td>
<td>Stephens &amp; Co.</td>
<td>Maintains</td>
<td>Equal-Weight</td>
<td>$29.00</td>
<td>$29.00</td>
</tr>
<tr>
<td>Stephen Willey</td>
<td>Stifel</td>
<td>Raises</td>
<td>Hold</td>
<td>$36.00</td>
<td>$30.00</td>
</tr>
<tr>
<td>Joseph Catanzaro</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Overweight</td>
<td>$38.00</td>
<td>$37.00</td>
</tr>
<tr>
<td>Ashwani Verma</td>
<td>UBS</td>
<td>Raises</td>
<td>Neutral</td>
<td>$34.00</td>
<td>$30.00</td>
</tr>
<tr>
<td>Silvan Tuerkcan</td>
<td>JMP Securities</td>
<td>Maintains</td>
<td>Market Outperform</td>
<td>$41.00</td>
<td>$41.00</td>
</tr>
<tr>
<td>Asthika Goonewardene</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$43.00</td>
<td>$42.00</td>
</tr>
<tr>
<td>Sudan Loganathan</td>
<td>Stephens &amp; Co.</td>
<td>Maintains</td>
<td>Equal-Weight</td>
<td>$29.00</td>
<td>$29.00</td>
</tr>
<tr>
<td>Robert Burns</td>
<td>HC Wainwright &amp; Co.</td>
<td>Maintains</td>
<td>Buy</td>
<td>$40.00</td>
<td>$40.00</td>
</tr>
<tr>
<td>Jefferson Harralson</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Overweight</td>
<td>$40.00</td>
<td>$30.00</td>
</tr>
<tr>
<td>Jay Olson</td>
<td>Oppenheimer</td>
<td>Lowers</td>
<td>Perform</td>
<td>$33.00</td>
<td>$41.00</td>
</tr>
<tr>
<td>Silvan Tuerkcan</td>
<td>JMP Securities</td>
<td>Maintains</td>
<td>Market Outperform</td>
<td>$41.00</td>
<td>$41.00</td>
</tr>
<tr>
<td>Jay Olson</td>
<td>Oppenheimer</td>
<td>Raises</td>
<td>Outperform</td>
<td>$41.00</td>
<td>$38.00</td>
</tr>
<tr>
<td>Asthika Goonewardene</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$42.00</td>
<td>$38.00</td>
</tr>
<tr>
<td>Silvan Tuerkcan</td>
<td>JMP Securities</td>
<td>Raises</td>
<td>Market Outperform</td>
<td>$41.00</td>
<td>$34.00</td>
</tr>
<tr>
<td>Joseph Catanzaro</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Overweight</td>
<td>$37.00</td>
<td>$36.00</td>
</tr>
<tr>
<td>Robert Burns</td>
<td>HC Wainwright &amp; Co.</td>
<td>Raises</td>
<td>Buy</td>
<td>$40.00</td>
<td>$29.00</td>
</tr>
<tr>
<td>Michael Schmidt</td>
<td>Guggenheim</td>
<td>Raises</td>
<td>Buy</td>
<td>$42.00</td>
<td>$33.00</td>
</tr>
<tr>
<td>Etzer Darout</td>
<td>BMO Capital</td>
<td>Raises</td>
<td>Market Perform</td>
<td>$40.00</td>
<td>$36.00</td>
</tr>
<tr>
<td>Jason Gerberry</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Neutral</td>
<td>$39.00</td>
<td>$35.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Exelixis. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Exelixis compared to the broader market.</li>
<li>Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of Exelixis's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Exelixis's market standing. Stay informed and make data-driven decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/EXEL/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Exelixis analyst ratings.</a>
<h2>Unveiling the Story Behind Exelixis</h2>
Exelixis is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its lead molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
<h3>Exelixis: Financial Performance Dissected</h3>
Market Capitalization: With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.
Revenue Growth: Exelixis's revenue growth over a period of 3 months has been noteworthy. As of 30 September, 2024, the company achieved a revenue growth rate of approximately 14.33%. This indicates a substantial increase in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Health Care sector.
Net Margin: Exelixis's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 21.87% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 5.37%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): Exelixis's ROA excels beyond industry benchmarks, reaching 4.12%. This signifies efficient management of assets and strong financial health.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.09.
<h2>How Are Analyst Ratings Determined?</h2>
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

EXEL

A Glimpse Into The Expert Outlook On Exelixis Through 21 Analysts

Providing a diverse range of perspectives from bullish to bearish, 12 analysts have published ratings on Fidelity National Info (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FIS#NYSE">FIS</a>) in the last three months.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">2</td>
<td align="right">4</td>
<td align="right">6</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have recently evaluated Fidelity National Info and provided 12-month price targets. The average target is $94.0, accompanied by a high estimate of $126.00 and a low estimate of $80.00. Experiencing a 6.0% decline, the current average is now lower than the previous average price target of $100.00. 
<img src="https://www.benzinga.com/files/images/story/2025/1739390427_0.png" alt="price target chart" />
<h2>Exploring Analyst Ratings: An In-Depth Overview</h2>
A comprehensive examination of how financial experts perceive Fidelity National Info is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Timothy Chiodo</td>
<td>UBS</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$81.00</td>
<td>$94.00</td>
</tr>
<tr>
<td>Daniel Perlin</td>
<td>RBC Capital</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$95.00</td>
<td>$104.00</td>
</tr>
<tr>
<td>Andrew Bauch</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$80.00</td>
<td>$88.00</td>
</tr>
<tr>
<td>James Friedman</td>
<td>Susquehanna</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$81.00</td>
<td>$103.00</td>
</tr>
<tr>
<td>Charles Nabhan</td>
<td>Stephens &amp; Co.</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$90.00</td>
<td>$100.00</td>
</tr>
<tr>
<td>Dominick Gabriele</td>
<td>Compass Point</td>
<td>Lowers</td>
<td>Buy</td>
<td>$113.00</td>
<td>$126.00</td>
</tr>
<tr>
<td>James Faucette</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$86.00</td>
<td>$92.00</td>
</tr>
<tr>
<td>Vasundhara Govil</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$92.00</td>
<td>$102.00</td>
</tr>
<tr>
<td>Daniel Perlin</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$104.00</td>
<td>$104.00</td>
</tr>
<tr>
<td>Andrew Bauch</td>
<td>Wells Fargo</td>
<td>Announces</td>
<td>Equal-Weight</td>
<td>$88.00</td>
<td>-</td>
</tr>
<tr>
<td>James Faucette</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$92.00</td>
<td>$87.00</td>
</tr>
<tr>
<td>Dominick Gabriele</td>
<td>Compass Point</td>
<td>Announces</td>
<td>Buy</td>
<td>$126.00</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Fidelity National Info. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of Fidelity National Info compared to the broader market.</li>
<li>Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Fidelity National Info's market standing. Stay informed and make data-driven decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/FIS/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Fidelity National Info analyst ratings.</a>
<h2>About Fidelity National Info</h2>
Fidelity National Information Services provides core processing and ancillary services to banks, but its business has expanded over time. By acquiring SunGard in 2015, the company now provides record-keeping and other services to investment firms. With the acquisition of Worldpay in 2019, FIS was providing payment processing services for merchants and holding leading positions in the United States and United Kingdom. But the company sold off a majority interest in Worldpay and now has only a minority stake.
<h3>Fidelity National Info's Economic Impact: An Analysis</h3>
Market Capitalization Analysis: The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.
Revenue Growth: Over the 3 months period, Fidelity National Info showcased positive performance, achieving a revenue growth rate of 3.13% as of 30 September, 2024. This reflects a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Financials sector.
Net Margin: The company's net margin is below industry benchmarks, signaling potential difficulties in achieving strong profitability. With a net margin of 8.72%, the company may need to address challenges in effective cost control.
Return on Equity (ROE): Fidelity National Info's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of 1.33%, the company may face hurdles in achieving optimal financial performance.
Return on Assets (ROA): Fidelity National Info's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of 0.65%, the company may face hurdles in achieving optimal financial returns.
Debt Management: With a below-average debt-to-equity ratio of 0.66, Fidelity National Info adopts a prudent financial strategy, indicating a balanced approach to debt management.
<h2>The Basics of Analyst Ratings</h2>
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. 
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

A Glimpse Into The Expert Outlook On Fidelity National Info Through 12 Analysts

AMETEK's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AME#NYSE">AME</a>) short percent of float has fallen 7.69% since its last report. The company recently reported that it has 1.97 million shares sold short, which is 0.96% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.28 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>AMETEK Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1739390424_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for AMETEK has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing AMETEK's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, AMETEK's peer group average for short interest as a percentage of float is 10.42%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

Trading Ideas

Looking Into AMETEK's Recent Short Interest

Carpenter Tech's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRS#NYSE">CRS</a>) short percent of float has risen 11.25% since its last report. The company recently reported that it has 2.79 million shares sold short, which is 7.81% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.42 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Carpenter Tech Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1739390418_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Carpenter Tech has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Carpenter Tech's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Carpenter Tech's peer group average for short interest as a percentage of float is 4.85%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Looking Into Carpenter Tech's Recent Short Interest

Teradata (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TDC#NYSE">TDC</a>) has been analyzed by 5 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $30.6, along with a high estimate of $37.00 and a low estimate of $25.00. A 10.0% drop is evident in the current average compared to the previous average price target of $34.00. 
<img src="https://www.benzinga.com/files/images/story/2025/1739390416_0.png" alt="price target chart" />
<h2>Deciphering Analyst Ratings: An In-Depth Analysis</h2>
The standing of Teradata among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Matthew Hedberg</td>
<td>RBC Capital</td>
<td>Lowers</td>
<td>Sector Perform</td>
<td>$29.00</td>
<td>$32.00</td>
</tr>
<tr>
<td>Howard Ma</td>
<td>Guggenheim</td>
<td>Lowers</td>
<td>Buy</td>
<td>$37.00</td>
<td>$42.00</td>
</tr>
<tr>
<td>Chirag Ved</td>
<td>Evercore ISI Group</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$32.00</td>
<td>$37.00</td>
</tr>
<tr>
<td>Raimo Lenschow</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Underweight</td>
<td>$25.00</td>
<td>$30.00</td>
</tr>
<tr>
<td>Raimo Lenschow</td>
<td>Barclays</td>
<td>Raises</td>
<td>Underweight</td>
<td>$30.00</td>
<td>$29.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Teradata. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Teradata compared to the broader market.</li>
<li>Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of Teradata's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
To gain a panoramic view of Teradata's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/TDC/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Teradata analyst ratings.</a>
<h2>About Teradata</h2>
Teradata Corp provides analytic data products and related services. The Company operates in data and analytics, which captures, integrates, stores, manages, and analyzes data of all types to answer business questions and deliver insight; and marketing applications, which offer marketing management products to help businesses win customer loyalty. Its solutions include components such as data warehousing, Asset optimization, Fraud prevention, Product innovation, and risk mitigation. A majority of the firm's revenue is generated in the United States.
<h3>Teradata: Financial Performance Dissected</h3>
Market Capitalization: Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.
Revenue Growth: Teradata's remarkable performance in 3 months is evident. As of 30 September, 2024, the company achieved an impressive revenue growth rate of 0.46%. This signifies a substantial increase in the company's top-line earnings. When compared to others in the Information Technology sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: Teradata's net margin is impressive, surpassing industry averages. With a net margin of 7.27%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): Teradata's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 32.0%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 1.95%, the company showcases effective utilization of assets.
Debt Management: The company faces challenges in debt management with a debt-to-equity ratio higher than the industry average. With a ratio of 4.74, caution is advised due to increased financial risk.
<h2>Analyst Ratings: Simplified</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

5 Analysts Have This To Say About Teradata

United Parcel Service's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UPS#NYSE">UPS</a>) short percent of float has risen 35.5% since its last report. The company recently reported that it has 16.73 million shares sold short, which is 2.29% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.93 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>United Parcel Service Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1739390413_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for United Parcel Service has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing United Parcel Service's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, United Parcel Service's peer group average for short interest as a percentage of float is 3.12%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Peering Into United Parcel Service's Recent Short Interest

Needham analyst Tom Nikic initiated coverage on VF Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VFC#NYSE">VFC</a>)<a target="_blank" href="https://www.benzinga.com/quote/VFC/analyst-ratings" rel="noreferrer noopener"> with a price forecast of $28.</a>
Per the analyst, the company is recovering from a difficult period that saw its earnings per share drop by about 80%.
Nikic highlights that CEO Bracken Darrell is implementing a plan to improve efficiency and margins, rejuvenate the Vans brand, and reduce debt leverage.
The analyst views VF Corporation as an attractive turnaround story, projecting FY28 EPS to exceed $2.00 (compared to pro-forma FY24 EPS of $0.64 excluding Supreme).
The stock could reach $40 within 2-3 years, leaving room for growth, especially considering its peak of around $100 before the pandemic, the analyst highlights.
Although challenges remain, the analyst highlights that the company is a &#8220;compelling turnaround story.&#8221;
Also Read: <a href="https://www.benzinga.com//node/43348516">North Face Parent VF Corp&#8217;s Q3 Marks First Revenue Growth In Nine Quarters, But Goldman Sachs Stays Neutral</a>
Nikic notes that VF Corporation previously had over $6 billion in net debt, but after selling Supreme for $1.5 billion and other non-core assets, along with better working-capital management and stabilizing fundamentals, <a href="https://www.benzinga.com//node/43302258">net debt is now around $3.3 billion.</a>
The company is expected to continue reducing debt, which will improve the profit and loss and provide more operational flexibility, the analyst adds.
Price Action: VFC shares are trading lower by 0.61% to $24.20 at last check Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/02/43663963/record-high-egg-prices-drive-inflation-higher-in-january" target="_blank" rel="noreferrer noopener">Record-High Egg Prices Drive Inflation Higher In January</a></li>
</ul>
Photo by Ground Picture on Shutterstock.

Analyst Color

Equities

News

Price Target

Initiation

Markets

General

VF Corp Is A 'Compelling Turnaround Story': Analyst Explains Why

Shares of Fidelity National Information Services, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FIS#NYSE">FIS</a>) are quiet Wednesday. This follows yesterday&#8217;s sell-off of 11.5%. The shares closed <a href="https://www.benzinga.com/25/02/43671119/analysts-lower-price-forecasts-for-fidelity-national-amid-banking-revenue-miss-details">around the $73 level</a>.
In financial markets, some price levels are more important for stocks than others and this is the case with the $73 level for Fidelity National. This is why it is our <a href="https://www.benzinga.com/topic/stock-of-the-day">Stock of the Day</a>.
This level was resistance for the stock in March and April 2024. There was a large amount of sell interest at this level. Every time the stock rallied to it, the sellers overpowered the buyers and pushed the shares lower.
But in May 2024, the buyers finally took out the resistance and the price moved higher. When this happened, many who sold regretted their decision to do so and decided to buy their shares back if they could at the same price they were sold for.
So, when the stock returned to this level in June 2024, they placed buy orders. And there were so many of these orders, that it created support.
Read Also: <a href="https://www.benzinga.com/etfs/new-etfs/25/02/43663523/new-treasury-etfs-target-liquidity-as-vanguard-expands-fixed-income-lineup">New Treasury ETFs Target Liquidity As Vanguard Expands Fixed-Income Lineup</a>
Seller's remorse can turn price levels that had been resistance into support. This happens if there are enough remorseful sellers placing buy orders at the price that had previously been resistance.
The same type of price action occurred at the $77.50 level. It was resistance from June 2024 through August 2024. Then it converted into a support level in January 2025.
Seller's remorse can also keep support levels intact for an extended period of time.
The $67.50 level was support in March 2024. Then it became support again in May 2024.
This happened because a number of the traders and investors who sold in March came to regret doing so when the price rallied soon after. Some decided that if they can buy their shares back at the same price they were sold for, they would.
When the stock returned to this level in May, they placed buy orders. And there were so many that it created support at the same price that had been support before.
As you can see on the chart below, yesterday's massive selloff came to an end when Fidelity National reached levels around $67.50. This wasn't a coincidence. It's an example of a stock finding support at a price level that had been support in the past.
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="548" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/12145053/116-1024x548.png" alt="" class="wp-image-779545" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/12145053/116-1024x548.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/12145053/116-300x161.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/12145053/116-768x411.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/12145053/116.png 1524w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
The best traders know that some price levels are more important than others. This allowed them to profit on yesterday's selloff because they could sense where the stock would find a bottom. If a stock is in decline, there is a good chance it will at a price that had previously been support or resistance.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/etfs/broad-u-s-equity-etfs/25/02/43667841/inflation-runs-hot-in-january-houston-we-have-a-problem-experts-warn">Inflation Runs Hot In January: &#8216;Houston, We Have A Problem,&#8217; Experts Warn</a></li>
</ul>
Image: Shutterstock

Technicals

Stock Of The Day: Seller's Remorse Leads To Profits For Some Traders In Fidelity National

Alibaba Group Holding Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BABA#NYSE">BABA</a>) shares are trading higher on Wednesday, along with other US-listed Chinese stocks, amid a tech rally driven by Chinese artificial intelligence (AI) <a href="https://www.benzinga.com/25/02/43637871/alibaba-clouds-growth-accelerates-with-ai-analyst-weighs-deepseeks-rising-competition">startup DeepSeek</a>.
What To Know: The Chinese startup released its DeepSeek R1 AI model in January, rattling the US market, especially American technology stocks, according to <a href="https://www.bbc.com/news/articles/c5yv5976z9po">BBC</a>. Reportedly, DeepSeek&#8217;s reasoning model, R1, is as powerful as OpenAI&#8217;s reasoning model, which was released at the end of last year.
Furthermore, DeepSeek claims to have developed and trained its model for a price tag of $6 million. OpenAI founder Sam Altman said ChatGPT-4 was trained at a cost of more than $100 million.
US-listed Chinese stocks are currently rallying, as DeepSeek&#8217;s release may have sparked speculation about whether American tech companies will retain their leadership in the AI sector. The lower cost and comparable performance of DeepSeek&#8217;s model have likely boosted investor confidence in these stocks, helping to fuel the recent surge.
Additionally, Chinese technology company Baidu, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIDU#NASDAQ">BIDU</a>) has announced plans to launch an updated version of its AI model later this year. According to <a href="https://www.cnbc.com/2025/02/12/china-tech-giant-baidu-to-release-next-generation-ai-model-this-year-as-deepseek-shakes-up-market.html">CNBC</a>, citing a source familiar with the matter, the new model, Ernie 5.0, is expected to feature upgrades in its multimodal capabilities.
Baidu&#8217;s Ernie 5.0 could further strengthen investor confidence in Chinese AI stocks, but its success will likely hinge on its capabilities and how it compares to models like ChatGPT.
See Also: <a href="https://www.benzinga.com/25/02/43667841/inflation-is-hot-and-getting-hotter">Inflation Runs Hot In January: &#8216;Houston We Have A Problem,&#8217; Experts Warn</a>
BABA Price Action: At the time of publication, Alibaba shares are trading 5.23% higher at $118.68, according to data from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.
Image: via Shutterstock

Movers

BABA

BIDU

What's Going On With Alibaba Shares Wednesday?

On Tuesday, Edwards Lifesciences (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EW#NYSE">EW</a>) reported fourth-quarter sales of $1.39 billion, beating the consensus of $1.36 billion. This represents a 9% year-over-year growth, supported by gains in all product groups.
Adjusted earnings per share came in at 59 cents, compared to <a target="_blank" href="https://www.benzinga.com/calendars/earnings" rel="noreferrer noopener">analysts&#8217; estimate of 55 cents</a>.
Transcatheter Aortic Valve Replacement (TAVR) global sales grew 5.3% year-over-year to $1.04 billion <a target="_blank" href="https://www.benzinga.com/pressreleases/25/02/b43640608/edwards-lifesciences-reports-fourth-quarter-results" rel="noreferrer noopener">in the fourth quarter</a>.
Transcatheter Mitral and Tricuspid Therapies (TMTT) sales reached $105 million for the quarter, supported by the strong adoption of the PASCAL repair system and EVOQUE replacement system. Full-year TMTT sales of $352 million marked a 77% year-over-year increase.
The Surgical segment reported sales of $244 million, up 6% year-over-year (+5% on constant currency), driven by robust adoption of RESILIA-based products.
The gross profit margin was 78.9%, or 79.0% adjusted, compared to 80.2% in the same period last year.&nbsp;
The fourth-quarter operating profit margin of 22.6%, or 25.6% adjusted, was in line with the company&#8217;s expectations.
&#8220;We exited the year in a strong position with three important growth drivers: TAVR, Mitral and Tricuspid, and two emerging opportunities in Structural Heart Failure and Aortic Regurgitation,&#8221; said Bernard Zovighian, Edwards&#8217; CEO. &#8220;In 2025, we expect to build on many catalysts across our businesses that will contribute to growth,&#8221; said Bernard Zovighian, Edwards&#8217; CEO.
Guidance: Edwards Lifesciences expects first quarter 2025 adjusted EPS of 58-64 cents versus the consensus of 59 cents and revenue of $1.35 billion—$1.43 billion versus the consensus of $1.412 billion.
Edwards&#8217; guidance for 2025 adjusted operating margins is 27%-28%, with annual operating profit margin expansion thereafter.
William Blair analyst Margaret Kaczor acknowledges that while Edwards Lifesciences&#8217; TAVR growth has potential, more evidence is needed to confirm it will reach the high end of 2025 guidance beyond Q1.
The analyst expects inefficiencies in catheter lab workflows to be temporary and believes long-term growth remains strong, particularly with the expansion of asymptomatic and moderate-risk indications over the next two years.
Meanwhile, continued strength in TMTT supports Edwards&#8217; market position and growth, with upcoming data and new product launches as potential catalysts.
Kaczor sees Edwards as a company with high-single- to low-double-digit sales growth, driven by increasing adoption in underpenetrated markets, structural heart expansion, and patient activation efforts to improve treatment access.
William Blair <a target="_blank" href="https://www.benzinga.com/quote/GILD/analyst-ratings" rel="noreferrer noopener">reiterates the Outperform rating</a>.
Price Action: EW stock is up 6.19% at $75.30 at last check Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/earnings/25/02/43657775/sonic-automotive-beats-q4-estimates-grows-technician-workforce-for-2025" target="_blank" rel="noreferrer noopener">Sonic Automotive Beats Q4 Estimates, Grows Technician Workforce For 2025</a></li>
</ul>

Earnings

Large Cap

Guidance

Health Care

Heart Devices-Focused Edwards Lifesciences Confident in 2025 Outlook, Analyst Sees Long-Term Strength

Biotech

CVRX

CVRx Announces New Evidence On Barostim Implantation Reducing Hospital Visits And Length Of Stay; Research Published In Journal Of Cardiac Failure

Once again this month Easy Income Portfolio proved its value as a safe haven during turbulent times. In spite of political and economic turmoil, our portfolio delivered a steady stem of consistent income and positive performance.
12 of 15 positions were higher during the month, and the average yield is 9.1%.
It was a very busy month indeed for the economy and markets.
Over the past month, the United States has witnessed a flurry of political and economic developments under President Donald Trump's administration, creating ripple effects across domestic and international markets. Policy shifts, trade tensions, and macroeconomic trends are setting the stage for a volatile but potentially opportunistic investment landscape. As always, when political and economic forces collide, sharp investors must separate the noise from the substance.
We had a temporary halt on the disbursement of various federal financial assistance programs. The freeze specifically targeted foreign aid, non-governmental organizations, diversity, equity, and inclusion (DEI) initiatives, and environmental projects tied to the Green New Deal. Essential programs, including Medicare and Social Security, were spared, but the impact of this abrupt action sent shockwaves through government agencies and non-profits dependent on federal support. As expected, the political backlash was immediate. Legal challenges mounted quickly, with federal judges blocking the freeze, citing potential constitutional violations. While the administration has signaled its intention to fight these rulings, the battle over federal spending is just getting started. Investors should watch how this plays out, as it could shape the fiscal policies of the next four years and impact sectors reliant on government contracts.
In a move reminiscent of his first term, President Trump announced steep tariffs on imports from Canada, Mexico, and China in late January. The new tariff schedule includes a 25% tax on most goods from Canada and Mexico, excluding crude oil and energy products, which will be taxed at 10%. A 10% tariff was also imposed on imports from China. These measures, set to take effect on February 4, have already provoked retaliatory action.
China has slapped new tariffs on American exports, including a 15% tax on coal and liquefied natural gas (Ticker: LNG), as well as a 10% tariff on crude oil, agricultural machinery, and large-engine vehicles. This escalation could weigh on sectors like industrials, agriculture, and energy, though it may also create buying opportunities for investors looking for undervalued plays in these industries.
The labor market added 143,000 jobs in January 2025, slightly below expectations. The unemployment rate ticked down to 4%, while average hourly wages rose 0.5% month-over-month and 4.1% year-over-year. Healthcare, retail, and government jobs led the way, while the mining sector saw declines.
However, economists are voicing concerns that Trump's policies—including tariffs and stricter immigration enforcement—may hinder future job growth and fuel inflation. Wage gains remain solid, which is good for consumers but presents challenges for businesses managing labor costs.
Inflation crept higher in January, with the Consumer Price Index (CPI) rising to 3%, up from December's 2.9%. Food and energy prices remain key contributors to rising costs. The increase has tempered market expectations for Federal Reserve rate cuts in 2025, though much will depend on how inflation trends over the coming months.
Tariffs, particularly those affecting steel, aluminum, and consumer goods, could push inflation even higher. Investors should monitor whether the Fed maintains its current 4.25%–4.50% interest rate target or adjusts its stance to combat inflationary pressures.
President Trump has placed an emphasis on reducing government spending and cutting the federal workforce. To spearhead this effort, he appointed Elon Musk to head the newly created &#8220;Department of Government Efficiency,&#8221; tasked with slashing $1 trillion from the budget. However, critics argue that the administration's push for additional tax cuts could exacerbate the national debt, which currently stands at $28.9 trillion (100% of GDP). Projections suggest debt levels could rise to 107% of GDP by 2027.
While reducing wasteful spending is a positive move, balancing this with tax cuts is a tricky equation. Investors should keep an eye on how these fiscal policies affect bond markets and interest rates.
In early January, Brent crude prices topped $80 per barrel due to tighter sanctions on Russian and Iranian oil exports and a severe cold snap in North America. However, by late January, prices pulled back, with Brent settling at $78.50 and WTI at $74.66. The shift came as the administration ramped up domestic production and pressured OPEC to keep prices in check.
The U.S. Energy Information Administration (EIA) has now revised its 2025 production forecast to 13.59 million barrels per day, highlighting expectations for increased domestic output. On the other hand, OPEC's output has declined for the second consecutive month, driven by lower Nigerian and Iranian exports.
U.S. natural gas prices have been swinging on fluctuating weather forecasts. An early January cold snap drove up demand and prices, but as temperatures moderated, prices softened. The EIA expects rising demand for LNG exports to keep prices elevated in 2025 and 2026, particularly as Europe and Asia seek alternatives to Russian gas.
January saw significant Treasury market volatility, with the 10-year yield peaking at 4.79% before closing the month at 4.54%. The uptick in inflation drove a sell-off in government debt, as investors recalibrated expectations for Fed policy.
Several&nbsp; of our positions include loans to small to mid-sized businesses here in the United States,
The Van Eck BDC Income ETF(Ticker: BIZD) and Blackstone Senior Loan ETF (Ticker: SRLN) are both comprised of entities that lend to this market.
Several companies in the Wisdom Tree Alternative Income Fund (Ticker: HYIN) lend to this market.
A resurgence in small and midsize businesses (SMBs) could be a significant catalyst for business development companies (BDCs). Several factors support this:
<ul>
<li>Reshoring and Manufacturing Growth: Supply chain disruptions have accelerated the shift back to domestic production, boosting demand for SMB financing. </li>
<li>Technology Leveling the Playing Field: AI, automation, and digital tools are helping SMBs compete against larger firms. </li>
<li>Private Credit Filling the Gap: BDCs are emerging as vital alternative lenders with banks tightening lending standards.</li>
</ul>
If SMBs thrive, BDCs benefit from increased loan originations, more substantial credit quality, and M&amp;A-driven liquidity events. Floating-rate loans remain a staple of BDC portfolios, making them attractive yield plays in the current environment.
Both Angel Oak Financial Strategies Income (Ticker: FINS) and Arrow Mark Financial (Ticker: AROW) should benefit from the positive economic impact this small business renaissance will have on the banking industry.
The day to the noise of the markets can make you crazy. If your primary goal is to collect income from your portfolio, or you prefer a more sedate approach to investing using reinvested income and dividends, the Easy Income Alternatives offers a low-stress alternative worth considering to help meet your long-term objectives.
It can also help preserve your sanity during times of economic, market, and political turbulence

Opinion

AROW

BIZD

Angel Oak Financial Strategies Income Term Trust Common Shares of Beneficial Interest

FINS

HYIN

SRLN

Easy Income Portfolio: February 2025 Update

Shares of Shopify Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHOP#NYSE">SHOP</a>) tanked in early trading on Wednesday, despite the company reporting <a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/02/43636620/shopifys-revenue-growth-outpaces-estimates-but-paypal-related-margin-impact-raises-questions-analyst">a fourth-quarter revenue beat</a>.
Here are some key analyst takeaways.
<ul>
<li>Piper Sandler <a href="https://www.benzinga.com/analyst-stock-ratings/analyst/61387715a3c6b90001ec2bda/clarke-jeffries">analyst Clarke Jeffries</a> reaffirmed a Neutral rating, while raising the price target from $94 to $104.</li>
<li>Goldman Sachs <a href="https://www.benzinga.com/analyst-stock-ratings/analyst/589dc33e43eaaa000122c59a/gabriela-borges">analyst Gabriela Borges</a> reiterated a Buy rating, while lifting the price target from $135 to $150.</li>
<li>JPMorgan <a href="https://www.benzinga.com/analyst-stock-ratings/analyst/611bba00b4035700018b67b6/reginald-smith">analyst Reginald Smith</a> maintained an Overweight rating, while raising the price target from $121 to $124.</li>
<li>Cantor Fitzgerald <a href="https://www.benzinga.com/analyst-stock-ratings/analyst/596f57cb35f48b00011db3ec/deepak-mathivanan">analyst Deepak Mathivanan</a> reiterated a Neutral rating and price target of $120.</li>
</ul>
Check out <a href="https://www.benzinga.com/analyst-stock-ratings">other analyst stock ratings</a>.
Piper Sandler: Shopify's revenues came in at $2.812 billion. It surpasses expectations, with growth accelerating to 31% year-on-year, Jeffries said in a note. Gross merchandise value (GMV) also accelerated to 26% year-on-year and came in at $94.5 billion, beating Street estimate of $92.7 billion.
Management guided to revenue growth in the mid-20s range for the first quarter, with gross profit growth in the low-20s range, the analyst stated. "All great news for Bulls, save for the company&#8217;s guarded commentary about near-term profitability expansion: prioritizing investment in key areas with the aim to maintain this level of FCF profitability for the near-term," he further wrote.
Goldman Sachs Shopify's GMV and revenues came in 2% and 3% higher than Street estimates, while its EBIT margin beat expectations by around 50 basis points, Borges said. Management guided to revenue growth in mid-20% year-on-year for the first quarter, versus consensus of 25%, she added.
Shopify continues to make progress in the enterprise segment, which could be "a key growth driver" this year, the analyst stated. The company's GMV growth rate as a percentage of US eCommerce growth continues to climb, "indicating that investments are coming from a position of strength i.e. accelerating market share gains," she further wrote.
JPMorgan: Shopify reported "another solid beat," with accelerating volume and revenue growth and upside to free cash flow margins. The company's "relatively soft" margin guidance for the first quarter does not reflect its longer-term margin expansion opportunity, Smith said.
Although the current momentum is not sustainable in the long term, the analyst wrote. But Shopify can &#8220;lean in on discretionary marketing spend" and position itself "extremely well for near-term earnings upside,"
Cantor Fitzgerald: Shopify's GMV growth accelerated by 2 percentage points to 26% year-on-year. That&#8217;s "the fastest growth in nearly 12 quarters," Mathivanan said. The implied operating income guidance for the first quarter is around 10% below the Street estimate, "which likely includes SHOP&#8217;s usual conservatism," he wrote.
The guidance does trigger some concern around the company's growth and profitability over the next few quarters, the analyst stated. Shopify has "a strong roadmap in several areas, he adds. They include Enterprise, Plus, advertising, and payments &#8211; which could keep deceleration modest over next few quarters."
Price Action: Shares of Shopify had declined by 1.93% to $121.21 at the time of publication on Thursday.
Read More:<a href="https://www.benzinga.com/25/02/43485175/amd-alphabet-snap-chipotle-and-tesla-why-these-5-stocks-are-on-investors-radars-today"></a> 
<ul>
<li><a href="https://www.benzinga.com/markets/equities/25/02/43649078/shopify-secures-12-of-us-e-commerce-pie-as-reebok-champion-and-warner-music-join-platform">Shopify Secures 12% Of US E-Commerce Pie As Reebok, Champion, And Warner Music Join Platform</a></li>
</ul>
Image: Shutterstock

Reiteration

SHOP

Shopify Posts Solid Q4, Analysts Expect Further Market Share Gains

Deep-pocketed investors have adopted a bullish approach towards Apple (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in AAPL usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 128 extraordinary options activities for Apple. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 48% leaning bullish and 44% bearish. Among these notable options, 30 are puts, totaling $1,605,012, and 98 are calls, amounting to $6,876,226.
<h3>Projected Price Targets</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $100.0 to $260.0 for Apple over the last 3 months. 
<h3>Volume &amp; Open Interest Trends</h3>
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Apple's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Apple's whale activity within a strike price range from $100.0 to $260.0 in the last 30 days. 
<h3>Apple Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1739389531_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>AAPL</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>02/21/25</td>
<td>$2.39</td>
<td>$2.38</td>
<td>$2.38</td>
<td>$237.50</td>
<td>$258.8K</td>
<td>6.8K</td>
<td>6.4K</td>
</tr>
<tr>
<td>AAPL</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$6.8</td>
<td>$6.75</td>
<td>$6.72</td>
<td>$255.00</td>
<td>$254.2K</td>
<td>5.4K</td>
<td>1.1K</td>
</tr>
<tr>
<td>AAPL</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>08/15/25</td>
<td>$5.9</td>
<td>$5.8</td>
<td>$5.8</td>
<td>$210.00</td>
<td>$214.6K</td>
<td>15.3K</td>
<td>615</td>
</tr>
<tr>
<td>AAPL</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$7.7</td>
<td>$7.6</td>
<td>$7.7</td>
<td>$235.00</td>
<td>$173.2K</td>
<td>18.8K</td>
<td>3.2K</td>
</tr>
<tr>
<td>AAPL</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>02/14/25</td>
<td>$2.16</td>
<td>$2.15</td>
<td>$2.15</td>
<td>$235.00</td>
<td>$146.8K</td>
<td>22.4K</td>
<td>77.3K</td>
</tr>
</tbody>
</table>

<h3>About Apple</h3>
Apple is among the largest companies in the world, with a broad portfolio of hardware and software products targeted at consumers and businesses. Apple's iPhone makes up a majority of the firm sales, and Apple's other products like Mac, iPad, and Watch are designed around the iPhone as the focal point of an expansive software ecosystem. Apple has progressively worked to add new applications, like streaming video, subscription bundles, and augmented reality. The firm designs its own software and semiconductors while working with subcontractors like Foxconn and TSMC to build its products and chips. Slightly less than half of Apple's sales come directly through its flagship stores, with a majority of sales coming indirectly through partnerships and distribution.
Following our analysis of the options activities associated with Apple, we pivot to a closer look at the company's own performance.
<h3>Current Position of Apple</h3>
<ul>
<li>With a trading volume of 26,212,611, the price of AAPL is up by 1.58%, reaching $236.31.</li>
<li>Current RSI values indicate that the stock is is currently neutral between overbought and oversold.</li>
<li>Next earnings report is scheduled for 78 days from now.</li>
</ul>
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>.
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Apple with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

Options

AAPL

Decoding Apple's Options Activity: What's the Big Picture?

Deep-pocketed investors have adopted a bullish approach towards Redfin (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RDFN#NASDAQ">RDFN</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in RDFN usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 11 extraordinary options activities for Redfin. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 45% leaning bullish and 45% bearish. Among these notable options, 8 are puts, totaling $631,860, and 3 are calls, amounting to $142,000.
<h3>What's The Price Target?</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $5.0 and $10.0 for Redfin, spanning the last three months.
<h3>Analyzing Volume &amp; Open Interest</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Redfin's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Redfin's significant trades, within a strike price range of $5.0 to $10.0, over the past month.
<h3>Redfin Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1739389527_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>RDFN</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>08/15/25</td>
<td>$1.42</td>
<td>$1.37</td>
<td>$1.38</td>
<td>$8.00</td>
<td>$276.0K</td>
<td>73</td>
<td>0</td>
</tr>
<tr>
<td>RDFN</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$0.78</td>
<td>$0.62</td>
<td>$0.74</td>
<td>$8.00</td>
<td>$77.8K</td>
<td>4.5K</td>
<td>2.1K</td>
</tr>
<tr>
<td>RDFN</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$0.78</td>
<td>$0.61</td>
<td>$0.75</td>
<td>$8.00</td>
<td>$77.0K</td>
<td>4.5K</td>
<td>1.0K</td>
</tr>
<tr>
<td>RDFN</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>05/16/25</td>
<td>$1.85</td>
<td>$1.84</td>
<td>$1.84</td>
<td>$8.00</td>
<td>$64.4K</td>
<td>1.1K</td>
<td>360</td>
</tr>
<tr>
<td>RDFN</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/16/26</td>
<td>$3.1</td>
<td>$3.0</td>
<td>$3.05</td>
<td>$10.00</td>
<td>$58.5K</td>
<td>1.4K</td>
<td>193</td>
</tr>
</tbody>
</table>

<h3>About Redfin</h3>
Redfin Corp is a residential real estate broker. It pairs its agents with the technology to create a service that is faster and costs less. The company meets customers through a listings-search website and mobile application. The company uses the same combination of technology and local service to originate mortgage loans and offer title and settlement services. It has five operating segments and three reportable segments, real estate services, rentals, and mortgage. The company generates the majority of its revenue from Real estate services.
After a thorough review of the options trading surrounding Redfin, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Redfin's Current Market Status</h3>
<ul>
<li>With a volume of 8,612,704, the price of RDFN is up 11.32% at $8.85. </li>
<li>RSI indicators hint that the underlying stock may be approaching overbought.</li>
<li>Next earnings are expected to be released in 15 days.</li>
</ul>
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Redfin, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

RDFN

This Is What Whales Are Betting On Redfin

Financial giants have made a conspicuous bearish move on Synopsys. Our analysis of options history for Synopsys (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNPS#NASDAQ">SNPS</a>) revealed 11 unusual trades.
Delving into the details, we found 18% of traders were bullish, while 54% showed bearish tendencies. Out of all the trades we spotted, 6 were puts, with a value of $388,095, and 5 were calls, valued at $190,103.
<h3>Expected Price Movements</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $480.0 to $600.0 for Synopsys over the last 3 months. 
<h3>Volume &amp; Open Interest Trends</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Synopsys's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Synopsys's significant trades, within a strike price range of $480.0 to $600.0, over the past month.
<h3>Synopsys Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1739389521_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>SNPS</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>02/21/25</td>
<td>$21.5</td>
<td>$19.9</td>
<td>$21.5</td>
<td>$530.00</td>
<td>$122.5K</td>
<td align="right">197</td>
<td align="right">58</td>
</tr>
<tr>
<td>SNPS</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>02/21/25</td>
<td>$21.4</td>
<td>$21.4</td>
<td>$21.4</td>
<td>$530.00</td>
<td>$92.0K</td>
<td align="right">197</td>
<td align="right">101</td>
</tr>
<tr>
<td>SNPS</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>03/20/26</td>
<td>$60.4</td>
<td>$53.5</td>
<td>$58.37</td>
<td>$500.00</td>
<td>$58.3K</td>
<td align="right">1</td>
<td align="right">10</td>
</tr>
<tr>
<td>SNPS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$36.9</td>
<td>$35.7</td>
<td>$35.7</td>
<td>$540.00</td>
<td>$49.9K</td>
<td align="right">32</td>
<td align="right">17</td>
</tr>
<tr>
<td>SNPS</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$46.3</td>
<td>$43.0</td>
<td>$43.8</td>
<td>$480.00</td>
<td>$43.8K</td>
<td align="right">46</td>
<td align="right">10</td>
</tr>
</tbody>
</table>

<h3>About Synopsys</h3>
Synopsys is a provider of electronic design automation software and intellectual property products. EDA software automates and aids in the chip design process, enhancing design accuracy, productivity, and complexity in a full-flow end-to-end solution. Synopsys' comprehensive portfolio is benefiting from a convergence of semiconductor companies moving up the stack of technologies toward systems-like companies, and systems companies moving down-stack toward in-house chip design. The resulting expansion in EDA customers alongside secular digitalization of various end markets benefits EDA vendors like Synopsys.
<h3>Current Position of Synopsys</h3>
<ul>
<li>With a volume of 556,654, the price of SNPS is down -2.72% at $514.76. </li>
<li>RSI indicators hint that the underlying stock is currently neutral between overbought and oversold.</li>
<li>Next earnings are expected to be released in 14 days.</li>
</ul>
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Synopsys, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

SNPS

This Is What Whales Are Betting On Synopsys

U.S. stocks traded mostly lower toward the end of trading, while the Nasdaq Composite edged higher on Wednesday.
The Dow traded down 0.47% to 44,381.89 while the NASDAQ rose 0.08% to 19,660.45. The S&amp;P 500 also fell, dropping, 0.25% to 6,053.09.
Check This Out: <a href="https://www.benzinga.com/analyst-ratings/price-target/25/02/43623929/wall-streets-most-accurate-analysts-spotlight-on-3-utilities-stocks-delivering-high-dividend-yields-6">Wall Street&#8217;s Most Accurate Analysts Spotlight On 3 Utilities Stocks Delivering High-Dividend Yields</a>
Leading and Lagging Sectors Consumer discretionary shares rose by 0.3% on Wednesday.
In trading on Wednesday, energy shares dipped by 2.2%.
Top Headline
CVS Health Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVS#NYSE">CVS</a>) shares jumped more than 16% on Wednesday after the company reported better-than-expected results for its fourth quarter.
The company posted fourth-quarter sales of $97.71 billion, beating the consensus of $97.19 billion.
Adjusted EPS of $1.19 decreased from $2.12 in the prior year, beating the consensus of $0.93, primarily due to a decline in the Health Care Benefits segment&#8217;s operating results, which reflect continued utilization pressure and the unfavorable impact of the Company&#8217;s Medicare Advantage star ratings for the 2024 payment year.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>Tivic Health Systems, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TIVC#NASDAQ">TIVC</a>) shares shot up 105% to $0.4825 after the company announced it acquired the exclusive license rights from Statera Biopharma for its Phase III TLR5 agonist entolimod treatment of acute radiation syndrome.</li>
<li>Shares of Xilio Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XLO#NASDAQ">XLO</a>)got a boost, surging 108% to $1.3600 after the company announced an option-to-license collaboration agreement with AbbVie to develop novel tumor-activated antibody-based immunotherapies.</li>
<li>Upstart Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UPST#NASDAQ">UPST</a>) shares were also up, gaining 31% to $88.26 after the company reported better-than-expected fourth-quarter financial results and issued FY25 revenue guidance above estimates. Multiple analysts upgraded the stock following the report.</li>
</ul>
Equities Trading DOWN
<ul>
<li>Spire Global, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPIR#NYSE">SPIR</a>) shares dropped 52% to $9.56 after the company filed a complaint against Kpler Holding, alleging Kpler failed to close on the acquisition of Spire&#8217;s maritime business. The company said given the expected delay, it intends to seek additional equity or debt financing.</li>
<li>Shares of Atomera Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATOM#NASDAQ">ATOM</a>) were down 38% to $5.40 following a fourth-quarter EPS miss and a year-over-year decline in sales results.</li>
<li>Similarweb Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMWB#NASDAQ">SMWB</a>) was down, falling 28% to $12.12 after the company missed quarterly earnings estimates.</li>
</ul>
Commodities In commodity news, oil traded down 2.4% to $71.53 while gold traded down 0.2% at $2,928.30.
Silver traded up 1.3% to $32.745 on Wednesday, while copper rose 2.2% to $4.7025.
Euro zone
European shares close higher today. The eurozone's STOXX 600 rose 0.11%, Germany's DAX 40 rose 0.50% and France's CAC 40 rose 0.17%. Spain's IBEX 35 Index rose 1.07%, while London's FTSE 100 rose 0.34%.
Asia Pacific Markets
Asian markets closed mostly higher on Wednesday, with Japan's Nikkei 225 gaining 0.42%, China's Shanghai Composite Index rising 0.85%, Hong Kong's Hang Seng Index jumping 2.64% and India's BSE Sensex falling 0.16%.
Economics
<ul>
<li>U.S. mortgage applications increased by 2.3% from the previous week during the first week of February, following a 2.2% rise from the earlier week.</li>
<li>The headline Consumer Price Index rose to 3% year-over-year in data released Wednesday, up 0.1 percentage points compared to December and above median economist forecasts of 2.9%, as tracked by TradingEconomics.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/25/02/43655780/how-to-earn-500-a-month-from-cisco-stock-ahead-of-q2-earnings">How To Earn $500 A Month From Cisco Stock Ahead Of Q2 Earnings</a></li>
</ul>

Eurozone

Commodities

ATOM

SMWB

SPIR

TIVC

UPST

Nasdaq Edges Higher; CVS Health Shares Jump Following Upbeat Earnings

Paycor HCM GAAP EPS of -$0.01 beats by $0.06, revenue of $180.4M beats by $3.31M

Reports Q2 revenue $180.44M, consensus $177.09M. The company said, "On January 7, 2025, we announced that we had entered into a definitive agreemen...

Paycor HCM reports Q2 adjusted EPS 14c, consensus 12c

Paycor Hcm, Inc. ( ($PYCR) ) has released its Q2 earnings. Here is a breakdown of the information Paycor Hcm, Inc. presented to its investors. Payc...

Paycor Reports Growth Amid Pending Paychex Merger

In a report released today, Patrick Walravens from JMP Securities maintained a Hold rating on Paycor HCM (PYCR – Research Report). The company's sh...

Paycor HCM (PYCR) Gets a Hold from JMP Securities

William Blair analyst Jake Roberge has maintained their neutral stance on PYCR stock, giving a Hold rating today. Jake Roberge has given his Hold r...

Balanced Hold Rating on Paycor HCM Amid Strong Q2 Performance and Uncertain Outlook

Robert W. Baird analyst Mark Marcon downgraded the rating on Paycor HCM (PYCR – Research Report) to a Hold today, setting a price target of $22.50....

Hold Rating Sustained for Paycor HCM Amid Acquisition by PAYX, Reflecting Limited Upside Potential

Baird downgraded Paycor HCM (PYCR) to Neutral from Outperform with a price target of $22.50, down from $28. The firm now believes is highly unlikel...

Paycor HCM downgraded to Neutral from Outperform at Baird

Analysts fell to the sidelines weighing in on Paycor HCM (PYCR – Research Report) and Qualys (QLYS – Research Report) with neutral ratings, indicat...

Analysts Are Neutral on These Technology Stocks: Paycor HCM (PYCR), Qualys (QLYS)

Paycor Hcm, Inc. (PYCR) has disclosed a new risk, in the Regulation category. Paycor Hcm, Inc. faces significant business risk due to the restricti...

Restrictive Covenants in Merger Agreement Pose Significant Risks to Paycor's Flexibility and Growth

Invesco Main Street Small Cap Fund Q4 2024 Commentary

ACHC

ADMA

ALAB

ALSN

ATMU

BRBR

BROS

BWXT

EPRT

ESAB

ITRI

LSCC

MTSI

PAYX

PFSI

PYCR

QLYS

SGRY

TMDX

WTFC

Legal

Press Releases

Paycor HCM Shareholders are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses

Paychex Enters into Definitive Agreement to Acquire Paycor

Shareholder Alert: Ademi LLP Investigates Whether Paycor HCM, Inc. Is Obtaining a Fair Price for Its Public Shareholders

Apax Funds to Sell Their Majority Stake in Paycor HCM, Inc. to Paychex, Inc.

$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Paycor HCM, Inc. - PYCR

Paycor Announces Date of Second Quarter Fiscal Year 2025 Financial Results

Advanced Human Capital Management (HCM) Solution Now Available to Convenience Retail and Wholesale Petroleum Operators as PDI Technologies Announces Entry into Embedded Partner Program with Paycor

Comments

Paycor HCM

空売り

Paycor HCM (NASDAQ:PYCR) 株価情報, 空売り情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル